These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21256914)

  • 1. Harm potential of magic mushroom use: a review.
    van Amsterdam J; Opperhuizen A; van den Brink W
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hallucinogenic mushrooms].
    Reingardiene D; Vilcinskaite J; Lazauskas R
    Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Between prohibitions: patterns and meanings of magic mushroom use in the UK.
    Riley SC; Blackman G
    Subst Use Misuse; 2008; 43(1):55-71. PubMed ID: 18189205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment of khat use in the Netherlands: a review based on adverse health effects, prevalence, criminal involvement and public order.
    Pennings EJ; Opperhuizen A; van Amsterdam JG
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):199-207. PubMed ID: 18783727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.
    Kopra EI; Ferris JA; Winstock AR; Young AH; Rucker JJ
    J Psychopharmacol; 2022 Aug; 36(8):965-973. PubMed ID: 35388724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The toxicological aspects of poisonings by psilocybine-containing mushrooms].
    Babakhanian RV; Bushuev ES; Kazankov SP; Kostyrko TA
    Sud Med Ekspert; 1997; 40(3):20-2. PubMed ID: 9304247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychoactive mushrooms - an update].
    Supprian T; Frey U; Supprian R; Rösler M; Wanke K
    Fortschr Neurol Psychiatr; 2001 Dec; 69(12):597-602. PubMed ID: 11753749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.
    Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC
    Drug Alcohol Depend; 2013 Jun; 130(1-3):245-8. PubMed ID: 23265089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.
    Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P
    J Psychopharmacol; 2020 Sep; 34(9):999-1007. PubMed ID: 32674668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Automutilation after consumption of hallucinogenic mushrooms].
    Attema-de Jonge ME; Portier CB; Franssen EJ
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2869-72. PubMed ID: 18257429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magic mushroom compound is a potential treatment for patients with major depression.
    Nurs Stand; 2016 Jun; 30(41):15. PubMed ID: 27286599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
    Musshoff F; Madea B; Beike J
    Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.
    van Amsterdam JG; van Laar M; Brunt TM; van den Brink W
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):55-63. PubMed ID: 22440552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.
    Riley S; Thompson J; Griffin C
    Int J Drug Policy; 2010 Nov; 21(6):445-51. PubMed ID: 20810266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].
    Lassen JF; Ravn HB; Lassen SF
    Ugeskr Laeger; 1990 Jan; 152(5):314-7. PubMed ID: 2301080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.
    Stebelska K
    Ther Drug Monit; 2013 Aug; 35(4):420-42. PubMed ID: 23851905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry and Toxicology of Major Bioactive Substances in
    Patocka J; Wu R; Nepovimova E; Valis M; Wu W; Kuca K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice.
    Zhuk O; Jasicka-Misiak I; Poliwoda A; Kazakova A; Godovan VV; Halama M; Wieczorek PP
    Toxins (Basel); 2015 Mar; 7(4):1018-29. PubMed ID: 25826052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.